Evidence map›Paper›PMID 20732812›Full record

ArticleBioorganic & medicinal chemistry letters2010

3D-QSAR CoMFA study of benzoxazepine derivatives as mGluR5 positive allosteric modulators.

Edward W Lowe, Alysia Ferrebee, Alice L Rodriguez, P Jeffrey Conn, Jens Meiler

Abstract read
In one paragraph

Article in Bioorganic & medicinal chemistry letters, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Edward W LoweCenter for Structural Biology, Vanderbilt University, Nashville, TN 37232 6600, USA.
Alysia Ferrebee
Alice L Rodriguez
P Jeffrey Conn
Jens Meiler

Funding

FUNCTIONS OF METABOTROPIC GLUTAMATE RECEPTOR SUBTYPESR01NS031373 · NINDS · VANDERBILT UNIVERSITY · PI CONN, P JEFFREY · 1993 to 2025
$6.2M
Cheminformatics of Allosteric mGluR Modulation promotes Therapeutic DevelopmentR01MH090192 · NIMH · VANDERBILT UNIVERSITY · PI MEILER, JENS · 2010 to 2013
$1.5M
Integrative Training in Therapeutic DiscoveryT90DA022873 · NIDA · VANDERBILT UNIVERSITY · PI MARNETT, LAWRENCE J. · 2006 to 2009
$1.3M
Novel Schizophrenia Therapeutics By Virtual High-Throughput ScreeningR21MH082254 · NIMH · VANDERBILT UNIVERSITY · PI MEILER, JENS · 2008 to 2009
$364k
NIDA NIH HHS T90 DA022873NIDA NIH HHS T90DA022873NIMH NIH HHS R01 MH090192NIMH NIH HHS R21 MH082254NIMH NIH HHS R21MH082254NINDS NIH HHS R01 NS031373
6 · The paper itself

Abstract

Positive allosteric modulation of the metabotropic glutamate receptor subtype 5 was studied by conducting a comparative molecular field analysis on 118 benzoxazepine derivatives. The model with the best predictive ability retained significant cross-validated correlation coefficients of q(2) = 0.58 (r(2) = 0.81) yielding a standard error of 0.20 in pEC(50) for this class of compounds. The subsequent contour maps highlight the structural features pertinent to the bioactivity values of benzoxazepines.

Indexed as

Allosteric RegulationBenzoxazinesDrug DesignModels, ChemicalModels, MolecularQuantitative Structure-Activity RelationshipReceptor, Metabotropic Glutamate 5Receptors, Metabotropic GlutamateStatic ElectricityBenzoxazinesReceptor, Metabotropic Glutamate 5Receptors, Metabotropic Glutamate

Identifiers

PMID20732812
PMCPMC2943337

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.